Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22677 | 317 | 32.6 | 59% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
799 | 11424 | AMYOTROPHIC LATERAL SCLEROSIS//SPINAL MUSCULAR ATROPHY//MOTOR NEURON DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SANATORIUM CHIBA | Address | 1 | 100% | 1% | 2 |
2 | ALS TREATMENT | Author keyword | 1 | 50% | 0% | 1 |
3 | BRAIN CORTEX SYNAPTOSOMES | Author keyword | 1 | 50% | 0% | 1 |
4 | HUMAN SPUMA RETROVIRUS | Author keyword | 1 | 50% | 0% | 1 |
5 | IMMUNOLOGICAL SUPPRESSION | Author keyword | 1 | 50% | 0% | 1 |
6 | LIONS HUMAN IMMUNOL | Address | 1 | 50% | 0% | 1 |
7 | NEUROSURG MDC 78 | Address | 1 | 50% | 0% | 1 |
8 | SPONTANEOUS ACETYLCHOLINE RELEASE | Author keyword | 1 | 50% | 0% | 1 |
9 | BIOL CELULAR NEUROCIENCIAS PROFESOR EDUARD | Address | 0 | 33% | 0% | 1 |
10 | CNRS EP 118 | Address | 0 | 33% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRAY MATTER DISEASE | 15 | 88% | 2% | 7 |
2 | MOTONEURON CELL LINE | 11 | 56% | 4% | 14 |
3 | INCREASE INTRACELLULAR CALCIUM | 7 | 67% | 2% | 6 |
4 | ALTERED CALCIUM | 3 | 42% | 2% | 5 |
5 | MOTOR NEURON DESTRUCTION | 2 | 67% | 1% | 2 |
6 | INTRANEURONAL IGG | 1 | 38% | 1% | 3 |
7 | LIPOPROTEIN VLDL RECEPTOR | 1 | 50% | 0% | 1 |
8 | NITRILOACETATE | 1 | 50% | 0% | 1 |
9 | SUPRAOPTIC CELLS | 1 | 50% | 0% | 1 |
10 | AMORPHOUS MATERIAL | 0 | 33% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The skin in amyotrophic lateral sclerosis | 2000 | 17 | 24 | 58% |
Novel Molecular Biomarkers at the Blood-Brain Barrier in ALS | 2014 | 0 | 61 | 41% |
MOLECULAR APPROACHES TO AMYOTROPHIC-LATERAL-SCLEROSIS | 1995 | 28 | 72 | 26% |
Circulating antibodies to NO- and ONOO-modified antigens in amyotrophic lateral sclerosis, Alzheimer's disease and multiple sclerosis | 2007 | 2 | 30 | 23% |
AMYOTROPHIC LATERAL SCLEROSIS - RECENT ADVANCES IN PATHOGENESIS AND THERAPEUTIC TRIALS | 1988 | 89 | 181 | 18% |
IMMUNOLOGICAL FINDINGS IN AMYOTROPHIC-LATERAL-SCLEROSIS | 1995 | 3 | 84 | 30% |
AMYOTROPHIC LATERAL SCLEROSIS .2. ETIOPATHOGENESIS | 1985 | 131 | 72 | 17% |
Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature | 2011 | 3 | 37 | 11% |
LONG-TERM TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS WITH PHTHALAZINOL | 1992 | 1 | 5 | 40% |
The relationship of posttraumatic stress and exogenous-organic disorders | 2010 | 0 | 36 | 14% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SANATORIUM CHIBA | 1 | 100% | 0.6% | 2 |
2 | LIONS HUMAN IMMUNOL | 1 | 50% | 0.3% | 1 |
3 | NEUROSURG MDC 78 | 1 | 50% | 0.3% | 1 |
4 | BIOL CELULAR NEUROCIENCIAS PROFESOR EDUARD | 0 | 33% | 0.3% | 1 |
5 | CNRS EP 118 | 0 | 33% | 0.3% | 1 |
6 | MED CARE NETWORKING | 0 | 33% | 0.3% | 1 |
7 | MED PROTEOM BIOANALYT | 0 | 33% | 0.3% | 1 |
8 | AVRAM STELLA GOREN GOLDSTEIN BIOTECHNOL EN | 0 | 25% | 0.3% | 1 |
9 | CPAE | 0 | 17% | 0.3% | 1 |
10 | ESTUD EGAS MONIZ | 0 | 17% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000219130 | AMYOTROPHIC LATERAL SCLEROSIS//SOD1//ALS |
2 | 0.0000142936 | BXSB MOUSE//LASHLEY MAZE//BIOBEHAV SCI DEGREE PROGRAM |
3 | 0.0000112315 | AMYOTROPHIC LATERAL SCLEROSIS//AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION//MOTOR NEURON DISEASE |
4 | 0.0000111513 | WOBBLER MOUSE//T 588//WOBBLER MICE |
5 | 0.0000110214 | PRIMARY LATERAL SCLEROSIS//BUNINA BODY//MOTOR NEURON DISEASE |
6 | 0.0000093710 | MULTIFOCAL MOTOR NEUROPATHY//CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY//CIDP |
7 | 0.0000073681 | NH15 CA2//PEPTIDE BLOCKER//QYNAD |
8 | 0.0000062746 | SUICIDE TRANSPORT//VOLKENSIN//IMMUNOLESIONING |
9 | 0.0000060261 | SPINAL AND BULBAR MUSCULAR ATROPHY//KENNEDYS DISEASE//KENNEDY DISEASE |
10 | 0.0000057194 | GUILLAIN BARRE SYNDROME//MILLER FISHER SYNDROME//ACUTE MOTOR AXONAL NEUROPATHY |